Livestock Health Market Size, Share and Growth Outlook 2026: By Product Type (Pharmaceuticals, Biologics and Vaccines, Medicinal Feed Additives, Diagnostics, Equipment and Disposables), By Animal Type, By End-User, Companies to 2034.
The global Livestock Health Market size is forecast to increase from $30.55 Billion in 2026 to $51.09 Billion in 2034 at a CAGR of 6.64% between 2026 and 2034.
The Livestock Health market report provides detailed analysis and outlook of Livestock Health segments including By Product Type (Pharmaceuticals, Biologics and Vaccines, Medicinal Feed Additives, Diagnostics, Equipment and Disposables ), By Animal Type (Cattle, Poultry, Swine, Sheep and Goats, Equines and Aquaculture / Fish), By End-User (Veterinary Hospitals and Clinics, Livestock Research Institutes, Commercial Farms and Breeders) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Livestock Health Industry Overview
Disease Prevention Remains Central to Global Livestock Health Strategies
The livestock health industry continues to prioritize disease surveillance, prevention, and veterinary infrastructure as governments and industry stakeholders seek to protect food production systems. The World Organisation for Animal Health published a global assessment highlighting the continued threat posed by avian influenza, African swine fever, and foot-and-mouth disease. The report emphasized the importance of strengthening animal health systems, expanding veterinary capacity, and increasing investment in disease monitoring programs. Effective livestock health management remains essential for maintaining productivity, safeguarding animal welfare, and reducing the risk of zoonotic disease transmission that can impact both agricultural and public health sectors.
Veterinary Pharmaceutical Innovation Expands Treatment Availability
The market continues to benefit from the introduction of new therapeutic options targeting chronic and acute animal health conditions. Cronus Pharma LLC launched Pimobendan Chewable Tablets, the first FDA-approved bioequivalent alternative to Vetmedin®. The product is indicated for managing mild, moderate, and severe congestive heart failure in dogs resulting from myxomatous mitral valve disease or dilated cardiomyopathy. Availability of bioequivalent veterinary medicines is improving treatment access while supporting broader management of cardiovascular diseases in companion animals. Such developments highlight ongoing investment in specialized animal therapeutics across veterinary healthcare markets.
Regulatory Approvals Strengthen Health Management in Food-Producing Animals
Regulatory activity remains a key driver of innovation and disease management within the livestock sector. The U.S. FDA Center for Veterinary Medicine continued issuing Emergency Use Authorizations and product approvals for therapies targeting diseases and parasites affecting cattle, sheep, and swine. Among these developments was the approval of generic ketoprofen for treatment of fever associated with bovine respiratory disease. Continued authorization of veterinary pharmaceuticals supports disease control programs, improves livestock productivity, and provides producers with additional tools for maintaining herd and flock health across commercial agricultural operations.
Livestock Health Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Livestock Health market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health, Ceva Sant? Animale, Virbac, Vetoquinol S.A., Neogen Corporation, Thermo Fisher Scientific Inc., Biog?nesis Bag?. The Livestock Health market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Livestock Health industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Livestock Health industry include- Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health, Ceva Sant? Animale, Virbac, Vetoquinol S.A., Neogen Corporation, Thermo Fisher Scientific Inc., Biog?nesis Bag?. The Livestock Health market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Livestock Health Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Livestock Health market remains one of the strongest-performing segments in the country.
The US Livestock Health Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Livestock Health market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Livestock Health industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Livestock Health markets
Canada's strong Livestock Health sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Livestock Health market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Livestock Health Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Livestock Health market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Livestock Health population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Livestock Health industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Livestock Health market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Livestock Health sales through 2034
France Livestock Health companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Livestock Health Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Livestock Health distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Livestock Health Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Livestock Health market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Livestock Health industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Livestock Health industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Livestock Health Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Livestock Health market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Livestock Health market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Livestock Health Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Livestock Health Market Segmentation
By Product Type
Pharmaceuticals
Biologics and Vaccines
Medicinal Feed Additives
Diagnostics
Equipment and Disposables
By Animal Type
Cattle
Poultry
Swine
Sheep and Goats
Equines and Aquaculture / Fish
By End-User
Veterinary Hospitals and Clinics
Livestock Research Institutes
Commercial Farms and Breeders
Leading Companies in Livestock Health Industry (2026)
Zoetis
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
Elanco Animal Health
Ceva Sant? Animale
Virbac
Vetoquinol S.A.
Neogen Corporation
Thermo Fisher Scientific Inc.
Biog?nesis Bag?
Countries Included
The Livestock Health market report provides detailed analysis and outlook of Livestock Health segments including By Product Type (Pharmaceuticals, Biologics and Vaccines, Medicinal Feed Additives, Diagnostics, Equipment and Disposables ), By Animal Type (Cattle, Poultry, Swine, Sheep and Goats, Equines and Aquaculture / Fish), By End-User (Veterinary Hospitals and Clinics, Livestock Research Institutes, Commercial Farms and Breeders) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Livestock Health Industry Overview
Disease Prevention Remains Central to Global Livestock Health Strategies
The livestock health industry continues to prioritize disease surveillance, prevention, and veterinary infrastructure as governments and industry stakeholders seek to protect food production systems. The World Organisation for Animal Health published a global assessment highlighting the continued threat posed by avian influenza, African swine fever, and foot-and-mouth disease. The report emphasized the importance of strengthening animal health systems, expanding veterinary capacity, and increasing investment in disease monitoring programs. Effective livestock health management remains essential for maintaining productivity, safeguarding animal welfare, and reducing the risk of zoonotic disease transmission that can impact both agricultural and public health sectors.
Veterinary Pharmaceutical Innovation Expands Treatment Availability
The market continues to benefit from the introduction of new therapeutic options targeting chronic and acute animal health conditions. Cronus Pharma LLC launched Pimobendan Chewable Tablets, the first FDA-approved bioequivalent alternative to Vetmedin®. The product is indicated for managing mild, moderate, and severe congestive heart failure in dogs resulting from myxomatous mitral valve disease or dilated cardiomyopathy. Availability of bioequivalent veterinary medicines is improving treatment access while supporting broader management of cardiovascular diseases in companion animals. Such developments highlight ongoing investment in specialized animal therapeutics across veterinary healthcare markets.
Regulatory Approvals Strengthen Health Management in Food-Producing Animals
Regulatory activity remains a key driver of innovation and disease management within the livestock sector. The U.S. FDA Center for Veterinary Medicine continued issuing Emergency Use Authorizations and product approvals for therapies targeting diseases and parasites affecting cattle, sheep, and swine. Among these developments was the approval of generic ketoprofen for treatment of fever associated with bovine respiratory disease. Continued authorization of veterinary pharmaceuticals supports disease control programs, improves livestock productivity, and provides producers with additional tools for maintaining herd and flock health across commercial agricultural operations.
Livestock Health Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Livestock Health market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health, Ceva Sant? Animale, Virbac, Vetoquinol S.A., Neogen Corporation, Thermo Fisher Scientific Inc., Biog?nesis Bag?. The Livestock Health market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Livestock Health industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Livestock Health Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Livestock Health companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Livestock Health markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Livestock Health industry include- Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health, Ceva Sant? Animale, Virbac, Vetoquinol S.A., Neogen Corporation, Thermo Fisher Scientific Inc., Biog?nesis Bag?. The Livestock Health market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Livestock Health Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Livestock Health market remains one of the strongest-performing segments in the country.
The US Livestock Health Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Livestock Health market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Livestock Health industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Livestock Health markets
Canada's strong Livestock Health sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Livestock Health market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Livestock Health Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Livestock Health market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Livestock Health population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Livestock Health industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Livestock Health market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Livestock Health sales through 2034
France Livestock Health companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Livestock Health Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Livestock Health distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Livestock Health Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Livestock Health market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Livestock Health industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Livestock Health industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Livestock Health Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Livestock Health market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Livestock Health market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Livestock Health Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Livestock Health Market Segmentation
By Product Type
Pharmaceuticals
Biologics and Vaccines
Medicinal Feed Additives
Diagnostics
Equipment and Disposables
By Animal Type
Cattle
Poultry
Swine
Sheep and Goats
Equines and Aquaculture / Fish
By End-User
Veterinary Hospitals and Clinics
Livestock Research Institutes
Commercial Farms and Breeders
Leading Companies in Livestock Health Industry (2026)
Zoetis
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
Elanco Animal Health
Ceva Sant? Animale
Virbac
Vetoquinol S.A.
Neogen Corporation
Thermo Fisher Scientific Inc.
Biog?nesis Bag?
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Livestock Health Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Livestock Health Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL LIVESTOCK HEALTH MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Livestock Health Markets in 2026
3.2. Global Historic and Forecast Livestock Health Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Livestock Health Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Livestock Health Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Livestock Health Value Chain
CHAPTER 4- LIVESTOCK HEALTH MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Livestock Health Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- LIVESTOCK HEALTH MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Type
Pharmaceuticals
Biologics and Vaccines
Medicinal Feed Additives
Diagnostics
Equipment and Disposables
By Animal Type
Cattle
Poultry
Swine
Sheep and Goats
Equines and Aquaculture / Fish
By End-User
Veterinary Hospitals and Clinics
Livestock Research Institutes
Commercial Farms and Breeders
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA LIVESTOCK HEALTH MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Livestock Health Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Livestock Health Market Trends and Growth Opportunities to 2034
7.5. North America Livestock Health Market Size Outlook by Type
7.6. North America Livestock Health Market Size Outlook by Application
7.7. North America Livestock Health Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Livestock Health Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Livestock Health Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Livestock Health Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Livestock Health Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Livestock Health Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Livestock Health Companies
CHAPTER 8- EUROPE LIVESTOCK HEALTH MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Livestock Health Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Livestock Health Market Trends and Growth Opportunities to 2034
8.5. Europe Livestock Health Market Size Outlook by Type
8.6. Europe Livestock Health Market Size Outlook by Application
8.7. Europe Livestock Health Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Livestock Health Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Livestock Health Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Livestock Health Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Livestock Health Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Livestock Health Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Livestock Health Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Livestock Health Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Livestock Health Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Livestock Health Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Livestock Health Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Livestock Health Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Livestock Health Companies
CHAPTER 9- ASIA PACIFIC LIVESTOCK HEALTH MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Livestock Health Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Livestock Health Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Livestock Health Market Size Outlook by Type
9.6. Asia Pacific Livestock Health Market Size Outlook by Application
9.7. Asia Pacific Livestock Health Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Livestock Health Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Livestock Health Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Livestock Health Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Livestock Health Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Livestock Health Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Livestock Health Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Livestock Health Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Livestock Health Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Livestock Health Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Livestock Health Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Livestock Health Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Livestock Health Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA LIVESTOCK HEALTH MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Livestock Health Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Livestock Health Market Trends and Growth Opportunities to 2034
10.5. South and Central America Livestock Health Market Size Outlook by Type
10.6. South and Central America Livestock Health Market Size Outlook by Application
10.7. South and Central America Livestock Health Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Livestock Health Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Livestock Health Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Livestock Health Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Livestock Health Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Livestock Health Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Livestock Health Companies
CHAPTER 11- MIDDLE EAST AND AFRICA LIVESTOCK HEALTH MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Livestock Health Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Livestock Health Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Livestock Health Market Size Outlook by Type
11.6. Middle East and Africa Livestock Health Market Size Outlook by Application
11.7. Middle East and Africa Livestock Health Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Livestock Health Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Livestock Health Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Livestock Health Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Livestock Health Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Livestock Health Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Livestock Health Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Livestock Health Industry
Zoetis
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
Elanco Animal Health
Ceva Sant? Animale
Virbac
Vetoquinol S.A.
Neogen Corporation
Thermo Fisher Scientific Inc.
Biog?nesis Bag?
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Livestock Health Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Livestock Health Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL LIVESTOCK HEALTH MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Livestock Health Markets in 2026
3.2. Global Historic and Forecast Livestock Health Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Livestock Health Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Livestock Health Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Livestock Health Value Chain
CHAPTER 4- LIVESTOCK HEALTH MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Livestock Health Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- LIVESTOCK HEALTH MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Type
Pharmaceuticals
Biologics and Vaccines
Medicinal Feed Additives
Diagnostics
Equipment and Disposables
By Animal Type
Cattle
Poultry
Swine
Sheep and Goats
Equines and Aquaculture / Fish
By End-User
Veterinary Hospitals and Clinics
Livestock Research Institutes
Commercial Farms and Breeders
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA LIVESTOCK HEALTH MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Livestock Health Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Livestock Health Market Trends and Growth Opportunities to 2034
7.5. North America Livestock Health Market Size Outlook by Type
7.6. North America Livestock Health Market Size Outlook by Application
7.7. North America Livestock Health Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Livestock Health Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Livestock Health Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Livestock Health Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Livestock Health Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Livestock Health Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Livestock Health Companies
CHAPTER 8- EUROPE LIVESTOCK HEALTH MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Livestock Health Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Livestock Health Market Trends and Growth Opportunities to 2034
8.5. Europe Livestock Health Market Size Outlook by Type
8.6. Europe Livestock Health Market Size Outlook by Application
8.7. Europe Livestock Health Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Livestock Health Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Livestock Health Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Livestock Health Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Livestock Health Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Livestock Health Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Livestock Health Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Livestock Health Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Livestock Health Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Livestock Health Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Livestock Health Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Livestock Health Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Livestock Health Companies
CHAPTER 9- ASIA PACIFIC LIVESTOCK HEALTH MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Livestock Health Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Livestock Health Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Livestock Health Market Size Outlook by Type
9.6. Asia Pacific Livestock Health Market Size Outlook by Application
9.7. Asia Pacific Livestock Health Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Livestock Health Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Livestock Health Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Livestock Health Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Livestock Health Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Livestock Health Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Livestock Health Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Livestock Health Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Livestock Health Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Livestock Health Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Livestock Health Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Livestock Health Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Livestock Health Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA LIVESTOCK HEALTH MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Livestock Health Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Livestock Health Market Trends and Growth Opportunities to 2034
10.5. South and Central America Livestock Health Market Size Outlook by Type
10.6. South and Central America Livestock Health Market Size Outlook by Application
10.7. South and Central America Livestock Health Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Livestock Health Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Livestock Health Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Livestock Health Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Livestock Health Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Livestock Health Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Livestock Health Companies
CHAPTER 11- MIDDLE EAST AND AFRICA LIVESTOCK HEALTH MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Livestock Health Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Livestock Health Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Livestock Health Market Size Outlook by Type
11.6. Middle East and Africa Livestock Health Market Size Outlook by Application
11.7. Middle East and Africa Livestock Health Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Livestock Health Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Livestock Health Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Livestock Health Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Livestock Health Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Livestock Health Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Livestock Health Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Livestock Health Industry
Zoetis
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
Elanco Animal Health
Ceva Sant? Animale
Virbac
Vetoquinol S.A.
Neogen Corporation
Thermo Fisher Scientific Inc.
Biog?nesis Bag?
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
